Showing results (61-70 of 161) with videos related to

Sort By:
Pageof 17
Pigment Cell & Melanoma Research|January 16, 2014
Inhibition of mutant BRAF splice variant signaling by next-generation, selective RAF inhibitorsKevin J Basile, Kaitlyn Le, Edward J Hartsough, et al.
Molecular Cancer Research : MCR|April 18, 2009
Mcl-1 is required for melanoma cell resistance to anoikisKaren Boisvert-Adamo, Whitney Longmate, Ethan V Abel, et al.
Molecular Cancer Research : MCR|July 26, 2014
FOXD3 modulates migration through direct transcriptional repression of TWIST1 in melanomaMichele B Weiss, Ethan V Abel, Neda Dadpey, et al.
Cell Reports|November 8, 2018
BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK AssociationMichael J Vido, Kaitlyn Le, Edward J Hartsough, et al.
The Journal of Biological Chemistry|July 4, 2006
Cyclin D3 expression in melanoma cells is regulated by adhesion-dependent phosphatidylinositol 3-kinase signaling and contributes to G1-S progressionLaurie S Spofford, Ethan V Abel, Karen Boisvert-Adamo, et al.
Iscience|August 28, 2023
Gene signature reveals decreased SOX10-dependent transcripts in malignant cells from immune checkpoint inhibitor-resistant cutaneous melanomasTimothy J Purwin, Signe Caksa, Ahmet Sacan, et al.
Cell Reports. Medicine|November 8, 2025
Aqueous humor biomarkers in ocular oncology: Insights and advancesLara Cheslow, Signe Caksa, Rachel E Cain, et al.
Pigment Cell & Melanoma Research|July 16, 2015
RAC1 P29S regulates PD-L1 expression in melanomaHa Linh Vu, Sheera Rosenbaum, Timothy J Purwin, et al.
Molecular Biology of the Cell|November 30, 2007
B-RAF regulation of Rnd3 participates in actin cytoskeletal and focal adhesion organizationR Matthew Klein, Laurie S Spofford, Ethan V Abel, et al.
Cancer Research|July 19, 2014
Function-blocking ERBB3 antibody inhibits the adaptive response to RAF inhibitorCurtis H Kugel, Edward J Hartsough, Michael A Davies, et al.
Pageof 17